Potential Upside OCUP..4.98..Ocuphire Pharma Bio-Pharm primary focus is developing and selling eye disorder therapies Leading drug candidate Nyxol eye drops, which are in Phase three clinical trials..These drops have the potential to help with dim light and night vision disturbances. Another drug APX 3330..Twice a day oral tablet that is used to treat retinal and choroidal vascular diseases.. VERY LOW FLOAT of 8.92 million Return on Equity 65% in four years Return on Equity 53% TipRanks Strong Buy with Target price of 24.67
Nice Buy At 52 Week Low ADUS..80.75..Addus homecare Corporation Provides personal care services in the patient's home, meal planning and preparation, feeding, dressing, hygiene and medication hospice provider giving non-medical supportive services on a continuous long-term basis Has working relationships with 180 care agencies across 25 states Revenue increase 7.9% year over year for Q1 Revenue has grown faster 18% than US Industry average of 9% Earnings Forecast to Grow 46% per year TipRanks Strong buy with Target price of 130.25
Investor Place High Risk High Reward Stocks AMD 84.65 ENBL 9.04 SAVE 33.15 AUY 4.36 SRNE 8.60 SOLO 4.52 COIN 229.29
News at 9 EVRI..21.21..Everi Holdings Expects Quarterly Records Revenue 167 million to 172 million Ner Income 31 million to 34 million Announced Refinancing Of ITS Outstanding Total Debt With Anticipated Prepayment of 144.9 million Provides Entertainment and Technology Solutions For The Casino,Interactive and Gaming Industry Return On Equity 535% in 4 years REvenue Forecast To Grow 22% per year Market Cap 1.8 billion StockTa Bullish Short And Very Bullish Long Barchart Strong Buy TipRanks Strong Buy with Target Price 24.17
Oversold Today ASTI..Down 18%...0142 ENZC...Down 10%...1675 GTEH...Down 13%...0014 GGII...Down 16%...0128 ZAAG..Down 23%...017
Silver In Demand At 52 Week Low PAAS..28.71..Pan American Silver Corporation Mining Company operates primarily in Central and South America Market cap 6 Billion Major Holders Van Eck $671 million Vanguard $185 Blackrock $149 million Trading below intrinsic value of 85.47 Revenue Forecast To Grow 18% per year TipRanks Strong Buy with Target price 40.50
News Early This Morning HALO 42.17..Halozyme VIIV Healthcare and Halozyme Global Collaboration And License Agreement For Enhanze Drug Delivery Technology To enable Development of Ultra Long-Acting medicines For HIV Company seeks to create therapies focused on human enzymes that alter tumors Market Cap 6 Billion Trading below intrinsic value of 160.87 Profit margin increased 97% in last year Return On Equity forecast to be 719% in four years Return on Assets 50% Revenue forecast to Grow 31% per year Earnings forecast To Grow 38% per year TipRanks Strong Buy with Target price 55.00
Pre-Market Mover ADIL..Up 35% 3.85..Adial Pharmaceuticals High Volume Yesterday Company developes prescription medications for addiction and related disorders Very Low Float 15 million
Sports Betting Play WNRS...0780 Yesterday Winners Announced..Can now refer customers in New Jersey in return for commission payments. Winners, Inc provides sports betting fans with high quality content, analysis, research, data, guidance and professional advice.
Upgraded To Outperform KOS..3.68..Kosmos Energy Independent Oil and Gas Exploration And production Company focused along the Atlantic Market Cap 1.5 Billion Holders FMR..LLC Holds $176 Million Blackrock $137 Million
News at 9 AMMX..5798 AmeraMex International Announced Just Inked Equipment Orders Totalling Approximately $1 Million Very Low Float 5.77 Million
News at 9 SRNE..8.63 Sorrento Announced Phase 2 Abivertinib Clinical Studies Have Completed Patient enrollment In USA and Brazil With top-Line Clinical Data Expected End of Q3 21
BMIX...0118 Brazil Minerals plans to begin Lithium Drilling Campaign..Its first lithium drilling campaign in its hard-rock lithium project in Northern Minas Gerais..The area to be drilled is known to contain spodumene and lepidolite, both lithium-bearing minerals.
SRNE..8.90..Sorrento Therapeutics Announced Today Inked Research Agreement With The US Navy For Pandemic Preparedness Multi-year Cooperative Research and Development Agreement With US Navel Medical Research Unit-No. 3 For Pandemic Prepardness Combating covid-19 Initial focus of the collaboration is to improve infectious disease readiness through surveillance and clinical diagnostic validation activities for Covistix/ Covitrack Diagnostic Tests and Covidrops/ Covi-Amg neutralizing antibody treatments for Covid-19 patients.
Upgraded To Buy With More Upside GSAT..Up 23% Tuesday 1.86..Globalstar Provides Mobile Satellite Services Worldwide Market Cap of 3.3 Billion Price Target of 3.25
